394 related articles for article (PubMed ID: 17052753)
21. Fusion gene transcripts and Ig/TCR gene rearrangements are complementary but infrequent targets for PCR-based detection of minimal residual disease in acute myeloid leukemia.
Boeckx N; Willemse MJ; Szczepanski T; van der Velden VH; Langerak AW; Vandekerckhove P; van Dongen JJ
Leukemia; 2002 Mar; 16(3):368-75. PubMed ID: 11896540
[TBL] [Abstract][Full Text] [Related]
22. Detection of the chromosome 16 CBF beta-MYH11 fusion transcript in myelomonocytic leukemias.
Poirel H; Radford-Weiss I; Rack K; Troussard X; Veil A; Valensi F; Picard F; Guesnu M; Leboeuf D; Melle J
Blood; 1995 Mar; 85(5):1313-22. PubMed ID: 7858261
[TBL] [Abstract][Full Text] [Related]
23. Common gene expression signatures in t(8;21)- and inv(16)-acute myeloid leukaemia.
Ichikawa H; Tanabe K; Mizushima H; Hayashi Y; Mizutani S; Ishii E; Hongo T; Kikuchi A; Satake M
Br J Haematol; 2006 Nov; 135(3):336-47. PubMed ID: 16989659
[TBL] [Abstract][Full Text] [Related]
24. Detection of a novel CBFB-MYH11 fusion transcript in acute myeloid leukemia M1 with inv(16)(p13q22).
Kurata K; Yamamoto K; Okazaki Y; Noguchi Y; Matsui K; Matsumoto H; Inui Y; Yakushijin K; Ito M; Nakamachi Y; Matsuoka H; Saegusa J; Minami H
Cancer Genet; 2020 Feb; 241():72-76. PubMed ID: 31353165
[TBL] [Abstract][Full Text] [Related]
25. Rare CBFB-MYH11 fusion transcripts in AML with inv(16)/t(16;16) are associated with therapy-related AML M4eo, atypical cytomorphology, atypical immunophenotype, atypical additional chromosomal rearrangements and low white blood cell count: a study on 162 patients.
Schnittger S; Bacher U; Haferlach C; Kern W; Haferlach T
Leukemia; 2007 Apr; 21(4):725-31. PubMed ID: 17287858
[TBL] [Abstract][Full Text] [Related]
26. Clinical aspects of expression of inversion 16 chromosomal fusion transcript CBFB/MYH11 in acute myelogenous leukemia subtype M1 with abnormal bone marrow eosinophilia.
Monahan BP; Rector JT; Liu PP; Cotelingam JD; Dahut W
Leukemia; 1996 Oct; 10(10):1653-4. PubMed ID: 8847901
[TBL] [Abstract][Full Text] [Related]
27. Identification of the chimeric protein product of the CBFB-MYH11 fusion gene in inv(16) leukemia cells.
Liu PP; Wijmenga C; Hajra A; Blake TB; Kelley CA; Adelstein RS; Bagg A; Rector J; Cotelingam J; Willman CL; Collins FS
Genes Chromosomes Cancer; 1996 Jun; 16(2):77-87. PubMed ID: 8818654
[TBL] [Abstract][Full Text] [Related]
28. RAD51 and XRCC3 polymorphisms: impact on the risk and treatment outcomes of de novo inv(16) or t(16;16)/CBFβ-MYH11(+) acute myeloid leukemia.
Liu L; Yang L; Mi Y; Wang J; Li J; Zhang Y; Ma X; Qin T; Xu Z; Xiao Z
Leuk Res; 2011 Aug; 35(8):1020-6. PubMed ID: 21296419
[TBL] [Abstract][Full Text] [Related]
29. Long-term disease-free acute myeloblastic leukemia with inv(16) is associated with PCR undetectable CBFbeta/MYH11 transcript.
Martinelli G; Ottaviani E; Testoni N; Montefusco V; Pastano R; Tura S
Haematologica; 2000 May; 85(5):552-5. PubMed ID: 10800179
[No Abstract] [Full Text] [Related]
30. A rapid RT-PCR screening assay incorporating multiplexed validated control genes for CBF rearrangements at diagnosis in AML.
Saal RJ; Marlton PV; Timson G; Gill DS; Waugh M; Springall F; Iland H
Pathology; 2004 Aug; 36(4):335-42. PubMed ID: 15370133
[TBL] [Abstract][Full Text] [Related]
31. Clinical implications of additional chromosomal abnormalities in adult acute myeloid leukemia with inv (16)/t(16;16)/CBFB::MYH11.
Gao J; Santana-Santos L; Fu L; Alvey E; Chen Q; Wolniak K; Xia Z; Aqil B; Behdad A; Ji P; Sukhanova M; Abaza Y; Altman JK; Chen YH; Lu X
Eur J Haematol; 2024 Jun; 112(6):964-974. PubMed ID: 38388794
[TBL] [Abstract][Full Text] [Related]
32. Detection of minimal residual disease in acute myelomonocytic leukemia with abnormal marrow eosinophils by nested polymerase chain reaction with allele specific amplification.
Hébert J; Cayuela JM; Daniel MT; Berger R; Sigaux F
Blood; 1994 Oct; 84(7):2291-6. PubMed ID: 7919348
[TBL] [Abstract][Full Text] [Related]
33. Two more inv(16) acute myeloid leukemia cases with infrequent CBFbeta-MYH11 fusion transcript: clinical and molecular findings.
Martinelli G; Ottaviani E; Buonamici S; Isidori A; Malagola M; Piccaluga P; Baccarani M
Haematologica; 2002 May; 87(5):554-5. PubMed ID: 12010674
[No Abstract] [Full Text] [Related]
34. inv(16)(p13q22) in chronic myelogenous leukemia in blast phase: a clinicopathologic, cytogenetic, and molecular study of five cases.
Merzianu M; Medeiros LJ; Cortes J; Yin C; Lin P; Jones D; Glassman A; Kantarjian H; Huh Y
Am J Clin Pathol; 2005 Nov; 124(5):807-14. PubMed ID: 16203287
[TBL] [Abstract][Full Text] [Related]
35. Development of a dual-color, double fusion FISH assay to detect RPN1/EVI1 gene fusion associated with inv(3), t(3;3), and ins(3;3) in patients with myelodysplasia and acute myeloid leukemia.
Shearer BM; Sukov WR; Flynn HC; Knudson RA; Ketterling RP
Am J Hematol; 2010 Aug; 85(8):569-74. PubMed ID: 20556821
[TBL] [Abstract][Full Text] [Related]
36. Acute myeloid leukaemia (FAB AML-M4Eo) with cryptic insertion of cbfb resulting in cbfb-Myh11 fusion.
Douet-Guilbert N; Chauveau A; Gueganic N; Guillerm G; Tous C; Le Bris MJ; Basinko A; Morel F; Ugo V; De Braekeleer M
Hematol Oncol; 2017 Sep; 35(3):385-389. PubMed ID: 28906004
[TBL] [Abstract][Full Text] [Related]
37. Prognostic value of minimal residual disease quantification by real-time reverse transcriptase polymerase chain reaction in patients with core binding factor leukemias.
Krauter J; Gorlich K; Ottmann O; Lubbert M; Dohner H; Heit W; Kanz L; Ganser A; Heil G
J Clin Oncol; 2003 Dec; 21(23):4413-22. PubMed ID: 14645432
[TBL] [Abstract][Full Text] [Related]
38. Genomic acute myeloid leukemia-associated inv(16)(p13q22) breakpoints are tightly clustered.
van der Reijden BA; Dauwerse HG; Giles RH; Jagmohan-Changur S; Wijmenga C; Liu PP; Smit B; Wessels HW; Beverstock GC; Jotterand-Bellomo M; Martinet D; Mühlematter D; Lafage-Pochitaloff M; Gabert J; Reiffers J; Bilhou-Nabera C; van Ommen GJ; Hagemeijer A; Breuning MH
Oncogene; 1999 Jan; 18(2):543-50. PubMed ID: 9927211
[TBL] [Abstract][Full Text] [Related]
39. Simple method for detection of MYH11 DNA rearrangements in patients with inv(16)(p13q22) and acute myeloid leukemia.
van der Reijden BA; Martinet D; Dauwerse JG; Giles RH; Wessels JW; Beverstock GC; Smit B; Mühlematter D; Jotterand Bellomo M; Gabert J; Lafage-Pochitaloff M; Reiffers J; Bilhou-Nabera C; van Ommen GJ; Hagemeijer A; Breuning MH
Leukemia; 1996 Sep; 10(9):1459-62. PubMed ID: 8751463
[TBL] [Abstract][Full Text] [Related]
40. Deletion of CBFB in a patient with acute myelomonocytic leukemia (AML M4Eo) and inversion 16.
Egan N; O'Reilly J; Chipper L; Higgins M; Herrmann R; Cannell P
Cancer Genet Cytogenet; 2004 Oct; 154(1):60-2. PubMed ID: 15381374
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]